LEGEND BIOTECH CORP-ADR (LEGN) Earnings History & Surprises
NASDAQ:LEGN • US52490G1022
19.14 USD
+0.17 (+0.9%)
At close: Mar 9, 2026
19.4 USD
+0.26 (+1.36%)
After Hours: 3/9/2026, 8:17:22 PM
Past quarterly earnings results for LEGEND BIOTECH CORP-ADR (LEGN), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 10, 2026
PeriodQ4 / 2025
EPS Estimate-$0.11
Revenue Estimate313.01M
Last Reported
Release DateNov 12, 2025
PeriodQ3 / 2025
EPS Reported-$0.22
EPS Surprise -155.43%
Revenue Surprise -2.02%
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.22 | -0.09 | -155.43% | 67.65% | 272.33M | 277.95M | -2.02% | 69.99% |
| Q2 2025 | -0.68 | -0.15 | -366.20% | -580.00% | 255.058M | 233.57M | 9.20% | 36.74% |
| Q1 2025 | -0.54 | -0.23 | -137.40% | -68.75% | 195.053M | 197.49M | -1.23% | 107.52% |
| Q4 2024 | 0.15 | -0.32 | 147.06% | 118.75% | 186.522M | 182.51M | 2.20% | 134.73% |
| Q3 2024 | -0.68 | -0.42 | -63.74% | -100.00% | 160.205M | 146.75M | 9.17% | 66.86% |
| Q2 2024 | -0.10 | -0.37 | 72.77% | 91.23% | 186.523M | 129.12M | 44.46% | 154.36% |
| Q1 2024 | -0.32 | -0.31 | -2.44% | 52.94% | 93.991M | 155.68M | -39.63% | 158.67% |
| Q4 2023 | -0.80 | -0.71 | -12.04% | -78.66% | 79.464M | 88.08M | -9.78% | -32.08% |
| Q3 2023 | -0.34 | -0.62 | 45.36% | 17.29% | 96.013M | 99.229M | -3.24% | 209.45% |
| Q2 2023 | -1.14 | -0.61 | -86.27% | 8.06% | 73.33M | 55.71M | 31.63% | 512.61% |
| Q1 2023 | -0.68 | -0.80 | 14.53% | -161.54% | 36.336M | 40.622M | -10.55% | -27.39% |
| Q4 2022 | -0.45 | - | -49.26% | 117.005M | 37.221M | 214.35% | 548.95% | |
| Q3 2022 | -0.41 | - | 4.40% | 31.027M | - | 83.81% | ||
| Q2 2022 | -1.24 | -0.43 | -188.69% | -287.50% | 11.97M | 32.325M | -62.97% | -40.83% |
| Q1 2022 | -0.26 | -0.47 | 44.59% | 13.33% | 50.04M | 17M | 194.35% | 265.79% |
| Q4 2021 | -0.30 | -0.42 | 28.26% | -36.36% | 18.03M | 14.51M | 24.26% | -55.05% |
| Q3 2021 | -0.43 | -0.36 | -18.75% | 14.00% | 16.88M | 7.99M | 111.26% | 43.66% |
| Q2 2021 | -0.32 | -0.34 | 7.04% | 74.60% | 20.23M | 9.316M | 117.15% | 74.40% |
| Q1 2021 | -0.30 | -0.36 | 15.97% | - | 13.68M | 4.42M | 209.50% | 18.44% |
| Q4 2020 | -0.22 | -0.29 | 23.87% | - | 40.11M | 13.26M | 202.49% | - |
| Q3 2020 | -0.50 | -0.31 | -59.84% | - | 11.75M | 13.26M | -11.39% | - |
| Q2 2020 | -1.26 | -0.27 | -375.11% | - | 11.6M | 13.26M | -12.52% | - |
| Q1 2020 | - | - | 11.55M | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-127.99%
Max EPS beat (4)
147.06%
Min EPS beat (4)
-366.20%
Revenue beat statistics
Revenue beat (4)
2
Average Revenue beat (4)
2.04%
Max Revenue beat (4)
9.20%
Min Revenue beat (4)
-2.02%
Analysis
In the last 4 quarters, LEGN has beaten EPS estimates in 1 out of 4 releases
LEGN has beaten revenue estimates in 2 out of the last 4 releases
In the last 4 quarters, LEGN reported -128.0% below the EPS estimates on average.
In the last 4 quarters, LEGN has beaten the revenue estimates by 2.0% on average.
LEGEND BIOTECH CORP-ADR / LEGN Earnings FAQ
When did LEGEND BIOTECH CORP-ADR (LEGN) report earnings last quarter?
LEGEND BIOTECH CORP-ADR (LEGN) last reported earnings on 11/12/2025.
Can you provide information on whether LEGEND BIOTECH CORP-ADR beat earnings estimates in the last quarter?
LEGEND BIOTECH CORP-ADR (LEGN) missed EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often LEGEND BIOTECH CORP-ADR beats earnings estimates?
In the last 4 quarters, LEGEND BIOTECH CORP-ADR (LEGN) has beaten EPS estimates in 1 out of 4 releases.